Tredje AP fonden Has $7.73 Million Stake in Humana Inc. (NYSE:HUM)

Tredje AP fonden trimmed its holdings in Humana Inc. (NYSE:HUM - Free Report) by 24.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,483 shares of the insurance provider's stock after selling 10,000 shares during the period. Tredje AP fonden's holdings in Humana were worth $7,734,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of HUM. FPC Investment Advisory Inc. acquired a new position in shares of Humana in the 4th quarter valued at approximately $27,000. Centricity Wealth Management LLC acquired a new position in shares of Humana in the fourth quarter valued at approximately $30,000. Ashton Thomas Securities LLC bought a new stake in shares of Humana during the third quarter worth $31,000. OFI Invest Asset Management bought a new stake in shares of Humana during the fourth quarter worth $33,000. Finally, Atwood & Palmer Inc. raised its holdings in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after acquiring an additional 60 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of NYSE HUM traded up $5.45 during midday trading on Tuesday, hitting $269.86. 1,632,536 shares of the company's stock were exchanged, compared to its average volume of 1,713,453. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $32.57 billion, a PE ratio of 27.12, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company's 50 day moving average price is $271.39 and its 200 day moving average price is $278.89.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.31%. Humana's dividend payout ratio is currently 35.58%.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of research reports. JPMorgan Chase & Co. lowered their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Piper Sandler increased their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research report on Thursday, February 13th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, Truist Financial lifted their price objective on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $285.68.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.32% of the company's stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.